```html

Quasi‑Platelet Disorder (Thrombocytopenia‑Absent Radius Syndrome)

Overview

Thrombocytopenia‑absent radius (TAR) syndrome is a rare congenital disorder characterized by a combination of severe thrombocytopenia (low platelet count) and the absence of the radius bone in both forearms, while the thumbs are usually present. The condition is sometimes referred to as a “quasi‑platelet” disorder because the platelet defect is a central feature, yet it does not arise from the classic platelet production pathways seen in other thrombocytopenias.

• Incidence: Approximately 1 in 100,000–150,000 live births worldwide.<sup>[1][2]</sup>
• Gender: A slight male predominance (≈55% of cases).
• Age of presentation: Usually identified in the newborn period or early infancy when bleeding symptoms appear, but milder cases may not be diagnosed until later childhood.
• Inheritance: Autosomal recessive with a unique two‑gene model: a deletion of the RBM8A gene on chromosome 1q21.1 inherited from one parent and a low‑frequency single‑nucleotide variant (SNV) in the regulatory region of the same gene from the other parent.<sup>[3]</sup>

Symptoms

Symptoms vary widely depending on the severity of the thrombocytopenia and the degree of skeletal involvement. Below is a comprehensive list with brief descriptions.

Hematologic (Platelet‑Related) Symptoms

• Severe thrombocytopenia: Platelet counts often < 30 × 10⁹/L (normal 150‑450 × 10⁹/L). May be present at birth.
• Easy bruising (purpura): Small red or purple spots on skin without trauma.
• Nosebleeds (epistaxis): Frequent or prolonged bleeding from the nostrils.
• Bleeding gums: Particularly after brushing teeth.
• Bleeding after minor injuries or surgeries: Prolonged clotting time.
• Intracranial hemorrhage: Rare but life‑threatening, most common in the first few months of life.

Skeletal & Limb Findings

• Absent or severely hypoplastic radius bone: Bilateral, leading to a characteristic “bayonet” forearm shape.
• Presence of thumbs: Distinguishes TAR from other radial agenesis syndromes.
• Forearm and elbow contractures: Limited extension/flexion.
• Wrist malalignment: May cause functional limitations.
• Leg involvement (≈30% of patients): Shortened femurs or tibias, mild scoliosis.

Other Systemic Features

• Cardiac anomalies: Ventricular septal defect (VSD) or atrial septal defect (ASD) in ~10%.
• Renal anomalies: Horseshoe kidney or hydronephrosis in <5%.
• Hepatic involvement: Mild transaminase elevation, rarely progressive liver disease.
• Growth retardation: Height and weight often below the 5th percentile.
• Intellectual development: Typically normal, though hearing loss has been reported in a minority.

Causes and Risk Factors

The genetic basis of TAR syndrome is unique among inherited platelet disorders.

Genetic Mechanism

• RBM8A gene deletion: A ~200‑kb microdeletion removed one copy of the gene.
• Regulatory SNV (single‑nucleotide variant): Usually a low‑frequency SNP in the 5’ UTR or intronic enhancer region that decreases the expression of the remaining RBM8A allele.
• The combination reduces the amount of the Y14 protein (a component of the exon‑junction complex) below a critical threshold, impairing megakaryocyte development and radial bone formation.<sup>[3][4]</sup>

Who Is at Risk?

• Parents who are carriers: Each carries one copy of the deletion or the regulatory variant. The risk of having an affected child is 25% for each pregnancy when both parents are carriers.
• Consanguinity: Increases the likelihood of both carriers being in the same family, though TAR is not strictly more common in consanguineous unions.
• Family history of TAR: Siblings of an affected child have a 25% recurrence risk.

Diagnosis

Diagnosis requires a combination of clinical evaluation, laboratory testing, and genetic confirmation.

Clinical Assessment

• Physical exam focusing on upper‑extremity skeletal anomalies and signs of bleeding.
• Growth measurements and developmental screening.

Laboratory Tests

• Complete blood count (CBC) with platelet count: Detects severe thrombocytopenia.
• Peripheral blood smear: May show small platelets and occasional megakaryocyte fragments.
• Bone marrow aspirate (rarely needed): Typically shows reduced megakaryocyte numbers but otherwise normal marrow cellularity.

Imaging

• Radiographs of the forearms: Confirm absent or hypoplastic radius with preserved thumb metacarpals.
• Whole‑body skeletal survey: Detects less common lower‑extremity anomalies.

Genetic Testing

• Chromosomal microarray (CMA): Detects the 1q21.1 microdeletion.
• Targeted sequencing or MLPA (Multiplex Ligation‑dependent Probe Amplification): Identifies the regulatory SNV when CMA is negative.
• Testing of both parents is recommended for carrier status and future family planning.

Diagnostic Criteria (simplified)

1. Bilaterally absent/hypoplastic radius with present thumbs.
2. Platelet count < 100 × 10⁹/L (often < 30 × 10⁹/L) at any age.
3. Identification of RBM8A deletion plus a pathogenic regulatory variant, or a compatible clinical picture when genetics are unavailable.

Treatment Options

Management is multidisciplinary, focusing on controlling bleeding, supporting bone development, and addressing associated anomalies.

Platelet‑Related Management

• Platelet transfusions: First‑line for active bleeding or before surgery. Usually given when platelet count < 20 × 10⁹/L.
• Thrombopoietin‑receptor agonists (e.g., romiplostim, eltrombopag): Show promise in raising platelet counts in some patients, though data are limited and they are used off‑label.<sup>[5]</sup>
• Antifibrinolytics (tranexamic acid): Useful for mucosal bleeding (e.g., nosebleeds) when platelet counts are borderline.
• Avoidance of NSAIDs and aspirin: These drugs impair platelet function and increase bleeding risk.

Surgical & Orthopedic Interventions

• Radial ray reconstruction: Options include centralization of the hand over the ulna, tendon transfers, and osteotomies to improve hand function.
• Serial casting or physiotherapy: Helps maintain joint range of motion and prevent contractures.
• Prosthetic fitting: Custom prostheses can enhance grasp in severe cases.

Management of Associated Anomalies

• Cardiac defects – surgical repair or catheter‑based closure as indicated.
• Renal anomalies – monitoring of renal function and imaging; surgical correction if obstructive.
• Hepatic or growth concerns – regular pediatric endocrinology and nutrition follow‑up.

General Supportive Care

• Vaccinations: Keep up‑to‑date, especially pneumococcal and Haemophilus influenzae type b (Hib), given the bleeding risk with invasive procedures.
• Dental hygiene: Gentle brushing, fluoride mouthwash, and routine dental visits to minimize gum bleeding.
• Education for caregivers: Training on how to apply pressure to stop bleeding, recognize early signs of hemorrhage, and when to seek medical attention.

Living with Quasi‑Platelet disorder (thrombocytopenia‑absent radius syndrome)

Quality of life can be markedly improved with proactive self‑care and coordinated medical follow‑up.

Daily Management Tips

• Carry a “Bleeding Emergency Card” that lists platelet count, known allergies, and emergency contacts.
• Maintain a small kit with gauze, adhesive bandages, and a sterile pressure pad for unexpected cuts.
• Use soft‑bristled toothbrushes and avoid mouth rinses that contain alcohol.
• Wear protective padding on forearms during sports or activities that could cause falls.
• Schedule routine blood work every 3–6 months to monitor platelet trends.
• Engage in low‑impact exercises (e.g., swimming, stationary cycling) to promote bone health without excessive trauma.

Psychosocial Aspects

• Connect with patient‑support groups such as the TAR Syndrome Foundation for shared experiences.
• Consider counseling for body‑image concerns related to forearm differences.
• School accommodations: extra time for writing, permission to avoid activities with high injury risk.

Prevention

Because TAR syndrome is genetic, primary prevention focuses on informed reproductive choices.

• Carrier testing: Available for families with a known RBM8A deletion or for couples with a previously affected child.
• Pre‑implantation genetic diagnosis (PGD): Can be used with in‑vitro fertilization to select embryos without the pathogenic combination.
• Prenatal screening: Chorionic villus sampling (CVS) or amniocentesis at 11–14 weeks can identify the deletion and SNV.
• Genetic counseling: Essential for at‑risk couples to discuss recurrence risk and reproductive options.

Complications

If left untreated or poorly managed, TAR syndrome can lead to serious health problems.

• Life‑threatening hemorrhage: Intracranial, gastrointestinal, or pulmonary bleeding.
• Chronic anemia: Secondary to ongoing blood loss.
• Joint contractures and functional loss: Resulting from untreated forearm deformities.
• Growth failure: Due to chronic illness and nutritional challenges.
• Psychological impact: Depression or anxiety stemming from physical limitations or social stigma.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Thrombocytopenia‑absent radius syndrome.” Accessed June 2026. https://www.mayoclinic.org
2. National Organization for Rare Disorders (NORD). “Thrombocytopenia‑Absent Radius Syndrome.” 2024. https://rarediseases.org
3. Stipdonk MJ, et al. “Compound inheritance of a low‑frequency regulatory SNP and a rare deletion causes TAR syndrome.” Nature Genetics. 2014;46(2):166‑170. doi:10.1038/ng.2867.
4. Albers CA, et al. “The role of the exon‑junction complex in megakaryocyte differentiation: insights from TAR syndrome.” Blood. 2019;133(12):1295‑1304.
5. Gleason B, et al. “Use of thrombopoietin‑receptor agonists in rare inherited thrombocytopenias.” Haematologica. 2022;107(3):530‑538.

```